Tobacco use disorder and the lungs.
Asthma
COPD
COVID-19
cessation
lung cancer
nicotine
respiratory infections
smoking
tobacco
Journal
Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
revised:
17
09
2020
received:
14
08
2020
accepted:
23
10
2020
pubmed:
4
11
2020
medline:
14
8
2021
entrez:
3
11
2020
Statut:
ppublish
Résumé
This narrative review provides a summary of the impact of tobacco smoking on the respiratory system and the benefits of smoking cessation. Tobacco smoking is one of the leading preventable causes of death world-wide and a major risk factor for lung cancer and chronic obstructive pulmonary disease. Smoking is also associated with an increased risk of respiratory infections and appears to be related to poorer outcomes among those with COVID-19. Non-smokers with second-hand smoke exposure also experience significant adverse respiratory effects. Smoking imposes enormous health- and non-health-related costs to societies. The benefits of smoking cessation, in both prevention and management of respiratory disease, have been known for decades and, to this day, cessation support remains one of the most important cost-effective interventions that health professionals can provide to people who smoke. Cessation at any age confers substantial health benefits, even in smokers with established morbidities. As other treatments for chronic respiratory disease advance and survival rates increase, smoking cessation treatment will become even more relevant. While smoking cessation interventions are available, the offer of these by clinicians and uptake by patients remain limited.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2559-2571Informations de copyright
© 2020 Society for the Study of Addiction.
Références
World Health Organization. WHO global report on trends in prevalence of tobacco use 2000-2025, third edition [internet]. World Health Organization; 2019. Available at: https://www.who.int/publications/i/item/who-global-report-on-trends-in-prevalence-of-tobacco-use-2000-2025-third-edition (accessed 09 August 2020).
Global Burden of Disease 2015 Tobacco Collaborators Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease study 2015. Lancet 2017; 389: 1885-1906.
Rodgman A., Perfetti T. A. The Chemical Components of Tobacco and Tobacco Smoke. Boca Raton: CRC Press; 2016. https://doi.org/10.1201/b13973
US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General [Internet]. Atlanta, GA: US Centers for Disease Control and Prevention; 2014 [cited 2020 Aug 5]. (Reports of the Surgeon General). Available at: http://www.ncbi.nlm.nih.gov/books/NBK179276/ (accessed 05 August 2020).
Dye J. A., Adler K. B. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax 1994; 49: 825-834.
Hogg J. C. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364: 709-721.
Stämpfli M. R., Anderson G. P. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 2009; 9: 377-384.
Elbehairy A. F., Ciavaglia C. E., Webb K. A., Guenette J. A., Jensen D., Mourad S. M. et al. Pulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease. Implications for dyspnea and exercise intolerance. Am J Respir Crit Care Med 2015; 191: 1384-1394.
Ofir D., Laveneziana P., Webb K. A., Lam Y.-M., O'Donnell D. E. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 622-629.
McDonough J. E., Yuan R., Suzuki M., Seyednejad N., Elliott W. M., Sanchez P. G. et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365: 1567-1575.
Humbert M., Guignabert C., Bonnet S., Dorfmüller P., Klinger J. R., Nicolls M. R. et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J 2019; 53: 1801887.
Peinado V. I., Pizarro S., Barberà J. A. Pulmonary vascular involvement in COPD. Chest 2008; 134: 808-814.
Burgel P.-R., Nadel J. A. Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J 2008; 32: 1068-1081.
Kim V., Criner G. J. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 228-237.
Sekhon H. S., Keller J. A., Proskocil B. J., Martin E. L., Spindel E. R. Maternal nicotine exposure upregulates collagen gene expression in fetal monkey lung. Association with alpha7 nicotinic acetylcholine receptors. Am J Respir Cell Mol Biol 2002; 26: 31-41.
Spindel E. R., McEvoy C. T. The role of nicotine in the effects of maternal smoking during pregnancy on lung development and childhood respiratory disease. Implications for dangers of E-cigarettes. Am J Respir Crit Care Med 2016; 193: 486-494.
Beck E. R., Taylor R. F., Lee L. Y., Frazier D. T. Bronchoconstriction and apnea induced by cigarette smoke: nicotine dose dependence. Lung 1986; 164: 293-301.
Lubin J. H., Caporaso N., Wichmann H. E., Schaffrath-Rosario A., Alavanja M. C. R. Cigarette smoking and lung cancer: modeling effect modification of total exposure and intensity. Epidemiology 2007; 18: 639-648.
Peto J. That the effects of smoking should be measured in pack-years: misconceptions 4. Br J Cancer 2012; 107: 406-407.
Peto J. That lung cancer incidence falls in ex-smokers: misconceptions 2. Br J Cancer 2011; 104: 389.
Stanley P. J., Wilson R., Greenstone M. A., MacWilliam L., Cole P. J. Effect of cigarette smoking on nasal mucociliary clearance and ciliary beat frequency. Thorax 1986; 41: 519-523.
Leopold P. L., O'Mahony M. J., Lian X. J., Tilley A. E., Harvey B.-G., Crystal R. G. Smoking is associated with shortened airway cilia. PLOS ONE 2009; 4: e8157.
Wu Q., Jiang D., Minor M., Chu H. W. Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLOS ONE 2014; 9: e108342.
Manzel L. J., Shi L., O'Shaughnessy P. T., Thorne P. S., Look D. C. Inhibition by cigarette smoke of nuclear factor-κB-dependent response to bacteria in the airway. Am J Respir Cell Mol Biol 2011; 44: 155-165.
Gerrard J. W., Heiner D. C., Ko C. G., Mink J., Meyers A., Dosman J. A. Immunoglobulin levels in smokers and non-smokers. Ann Allergy 1980; 44: 261-262.
Yeung M. C., Buncio A. D. Leukocyte count, smoking, and lung function. Am J Med 1984; 76: 31-37.
Bridges R. B., Hsieh L. Effects of cigarette smoke fractions on the chemotaxis of polymorphonuclear leukocytes. J Leukoc Biol 1986; 40: 73-85.
Ginns L. C., Goldenheim P. D., Miller L. G., Burton R. C., Gillick L., Colvin R. B. et al. T-lymphocyte subsets in smoking and lung cancer: analysis of monoclonal antibodies and flow cytometry. Am Rev Respir Dis 1982; 126: 265-269.
Ouyang Y., Virasch N., Hao P., Aubrey M. T., Mukerjee N., Bierer B. E. et al. Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts. J Allergy Clin Immunol 2000; 106: 280-287.
Hagiwara E., Takahashi K. I., Okubo T., Ohno S., Ueda A., Aoki A. et al. Cigarette smoking depletes cells spontaneously secreting Th(1) cytokines in the human airway. Cytokine 2001; 14: 121-126.
Miller L. G., Goldstein G., Murphy M., Ginns L. C. Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest 1982; 82: 526-529.
Sopori M. L., Kozak W., Savage S. M., Geng Y., Soszynski D., Kluger M. J. et al. Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology 1998; 23: 189-204.
Mili F., Flanders W. D., Boring J. R., Annest J. L., Destefano F. The associations of race, cigarette smoking, and smoking cessation to measures of the immune system in middle-aged men. Clin Immunol Immunopathol 1991; 59: 187-200.
Genco R. J. Current view of risk factors for periodontal diseases. J Periodontol 1996; 67: 1041-1049.
Ferreira Antunes J. L., Toporcov T. N., Biazevic M. G. H., Boing A. F., Scully C., Petti S. Joint and independent effects of alcohol drinking and tobacco smoking on oral cancer: a large case-control study. PLOS ONE 2013; 8: e68132.
Tomar S. L., Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol 2000; 71: 743-751.
Frye R. E., Schwartz B. S., Doty R. L. Dose-related effects of cigarette smoking on olfactory function. JAMA 1990; 263: 1233-1236.
Kim K. S., Kim J. H., Park S. Y., Won H.-R., Lee H.-J., Yang H. S. et al. Smoking induces oropharyngeal narrowing and increases the severity of obstructive sleep apnea syndrome. Sleep Med 2012; 8: 367-374.
Wetter D. W., Young T. B., Bidwell T. R., Badr M. S., Palta M. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994; 154: 2219-2224.
Phillips B. A., Danner F. J. Cigarette smoking and sleep disturbance. Arch Intern Med 1995; 155: 734-737.
Punjabi N. M. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008; 5: 136-143.
Arcavi L., Benowitz N. L. Cigarette smoking and infection. Arch Intern Med 2004; 164: 2206-2216.
Murin S., Bilello K. S. Respiratory tract infections: another reason not to smoke. Cleve Clin J Med 2005; 72: 916-920.
Groskreutz D. J., Monick M. M., Babor E. C., Nyunoya T., Varga S. M., Look D. C. et al. Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication. Am J Respir Cell Mol Biol 2009; 41: 189-198.
Finklea J. F., Hasselblad V., Riggan W. B., Nelson W. C., Hammer D. I., Newill V. A. Cigarette smoking and hemagglutination inhibition response to influenza after natural disease and immunization. Am Rev Respir Dis 1971; 104: 368-376.
van Eeden S. F., Hogg J. C. The response of human bone marrow to chronic cigarette smoking. Eur Respir J 2000; 15: 915-921.
Calfee C. S., Matthay M. A., Kangelaris K. N., Siew E. D., Janz D. R., Bernard G. R. et al. Cigarette smoke exposure and the acute respiratory distress syndrome. Crit Care Med 2015; 43: 1790-1797.
Hsieh S. J., Zhuo H., Benowitz N. L., Thompson B. T., Liu K. D., Matthay M. A. et al. Prevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome. Crit Care Med 2014; 42: 2058-2068.
Lu Q., Sakhatskyy P., Grinnell K., Newton J., Ortiz M., Wang Y. et al. Cigarette smoke causes lung vascular barrier dysfunction via oxidative stress-mediated inhibition of RhoA and focal adhesion kinase. Am J Physiol Lung Cell Mol Physiol 2011; 301: L847-L857.
Mason R. J. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J 2020; 55: 2000607.
Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z. et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382: 1177-1179.
Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-273.
Leung J. M., Yang C. X., Tam A., Shaipanich T., Hackett T.-L., Singhera G. K. et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J 2020; 55: 2000688.
Hippisley-Cox J., Young D., Coupland C., Channon K. M., Tan P. S., Harrison D. A. et al. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart Br Card Soc 2020; 106: 1503-1511.
Simons D., Shahab L., Brown J., Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 7). Addiction. 2020; https://doi.org/10.1111/add.15276. Epub ahead of print.
Farsalinos K., Angelopoulou A., Alexandris N., Poulas K. COVID-19 and the nicotinic cholinergic system. Eur Respir J 2020; 56: 2001589.
Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
World Health Organization. Smoking and COVID-19: Scientific Brief [internet]. 2020. Available at: https://www.who.int/news-room/commentaries/detail/smoking-and-covid-19 (accessed 05 August 2020).
Wynder E. L., Graham E. A. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma: a study of six hundred and eighty-four proved cases. JAMA 1950; 143: 329-336.
Doll R., Hill A. B. Smoking and carcinoma of the lung. BMJ 1950; 2: 739-748.
Doll R., Hill A. B. Lung cancer and other causes of death in relation to smoking. BMJ 1956; 2: 1071-1081.
Hammond E. C. Smoking in relation to the death rates of one million men and women. Natl Cancer Inst Monogr 1966; 19: 127-204.
Thun M. J., Heath C. W. Changes in mortality from smoking in two American Cancer Society prospective studies since 1959. Prev Med 1997; 26: 422-426.
Lee P. N., Forey B. A., Coombs K. J. Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer 2012; 12: 385.
Barta J. A., Powell C. A., Wisnivesky J. P. Global epidemiology of lung cancer. Ann Glob Health 2019; 22: 1.
Travis W. D., Brambilla E., Nicholson A. G., Yatabe Y., Austin J. H. M., Beasley M. B. et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015; 10: 1243-1260.
Janssen-Heijnen M. L., Coebergh J. W., Klinkhamer P. J., Schipper R. M., Splinter T. A., Mooi W. J. Is there a common etiology for the rising incidence of and decreasing survival with adenocarcinoma of the lung? Epidemiology 2001; 12: 256-258.
Sholl L. M. Biomarkers in lung adenocarcinoma: a decade of progress. Arch Pathol Lab Med 2015; 139: 469-480.
Villalobos P., Wistuba I. I. Lung cancer biomarkers. Hematol Oncol Clin North Am 2017; 31: 13-29.
Freedman N. D., Leitzmann M. F., Hollenbeck A. R., Schatzkin A., Abnet C. C. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol 2008; 9: 649-656.
Bagnardi V., Rota M., Botteri E., Scotti L., Jenab M., Bellocco R. et al. Alcohol consumption and lung cancer risk in never smokers: a meta-analysis. Ann Oncol 2011; 22: 2631-2639.
Le Marchand L., Wilkens L. R., Kolonel L. N. Ethnic differences in the lung cancer risk associated with smoking. Cancer Epidemiol Biomark Prev 1992; 1: 103-107.
Baik C. S., Strauss G. M., Speizer F. E., Feskanich D. Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses’ Health Study. Cancer Epidemiol Biomark Prev 2010; 19: 2525-2533.
Eisner M. D., Anthonisen N., Coultas D., Kuenzli N., Perez-Padilla R., Postma D. et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182: 693-718.
Soriano J. B., Kendrick P. J., Paulson K. R., Gupta V., Abrams E. M., Adedoyin R. A. et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2020; 8: 585-596.
World Health Organization. Chronic Respiratory Diseases [internet]. Available at: http://www.who.int/health-topics/chronic-respiratory-diseases (accessed 15 July 2020).
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: 2020 Report [internet]. Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2020. Available at: https://goldcopd.org/gold-reports/ (accessed 09 August 2020).
Payne M., Kjelsberg M. Respiratory symptoms, lung function, and smoking habits in an adult population. Am J Public Health Nations Health 1964; 54: 261-277.
Ashley F., Kannel W. B., Sorlie P. D., Masson R. Pulmonary function: relation to aging, cigarette habit, and mortality. Ann Intern Med 1975; 82: 739-745.
Fletcher C., Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648.
Downs S. H., Brändli O., Zellweger J.-P., Schindler C., Künzli N., Gerbase M. W. et al. Accelerated decline in lung function in smoking women with airway obstruction: SAPALDIA 2 cohort study. Respir Res 2005; 6: 45.
McLeish A. C., Zvolensky M. J. Asthma and cigarette smoking: a review of the empirical literature. J Asthma 2010; 47: 345-361.
Thomson N. C., Chaudhuri R., Livingston E. Asthma and cigarette smoking. Eur Respir J 2004; 24: 822-833.
Hanrahan J. P., Brown R. W., Carey V. J., Castile R. G., Speizer F. E., Tager I. B. Passive respiratory mechanics in healthy infants. Effects of growth, gender, and smoking. Am J Respir Crit Care Med 1996; 154: 670-680.
Mitchell E. A., Milerad J. Smoking and the sudden infant death syndrome. Rev Environ Health 2006; 21: 81-103.
Anderson T. M., Lavista Ferres J. M., Ren S. Y., Moon R. Y., Goldstein R. D., Ramirez J.-M. et al. Maternal smoking before and during pregnancy and the risk of sudden unexpected infant death. Pediatrics 2019; 143: e20183325.
Taylor J. A., Sanderson M. A reexamination of the risk factors for the sudden infant death syndrome. J Pediatr 1995; 126: 887-891.
Horne R. S. C., Parslow P. M., Ferens D., Bandopadhayay P., Osborne A., Watts A. M. et al. Arousal responses and risk factors for sudden infant death syndrome. Sleep Med 2002; 3: S61-S65.
US Office on Smoking and Health. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General [internet]. Atlanta (GA): US Centers for Disease Control and Prevention; 2006 (Publications and Reports of the Surgeon General). Available at: http://www.ncbi.nlm.nih.gov/books/NBK44324/ (accessed 05 August 2020).
Maedel C., Kainz K., Frischer T., Reinweber M., Zacharasiewicz A. Increased severity of respiratory syncytial virus airway infection due to passive smoke exposure. Pediatr Pulmonol 2018; 53: 1299-1306.
Lin H.-H., Ezzati M., Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLOS Med 2007; 4: e20.
Young S., Le Souëf P. N., Geelhoed G. C., Stick S. M., Turner K. J., Landau L. I. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med 1991; 324: 1168-1173.
Cook D. G., Strachan D. P. Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax 1997; 52: 1081-1094.
Feleszko W., Ruszczyński M., Jaworska J., Strzelak A., Zalewski B. M., Kulus M. Environmental tobacco smoke exposure and risk of allergic sensitisation in children: a systematic review and meta-analysis. Arch Dis Child 2014; 99: 985-992.
Putcha N., Barr R. G., Han M. K., Woodruff P. G., Bleecker E. R., Kanner R. E. et al. Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort. Thorax 2016; 71: 411-420.
Perret J. L., Walters H., Johns D., Gurrin L., Burgess J., Lowe A. et al. Mother's smoking and complex lung function of offspring in middle age: a cohort study from childhood. Respirol Carlton Vic 2016; 21: 911-919.
Flouris A. D., Vardavas C. I., Metsios G. S., Tsatsakis A. M., Koutedakis Y. Biological evidence for the acute health effects of secondhand smoke exposure. Am J Physiol Lung Cell Mol Physiol 2010; 298: L3-L12.
Kim C. H., Lee Y.-C. A., Hung R. J., McNallan S. R., Cote M. L., Lim W.-Y. et al. Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the international lung cancer consortium (ILCCO). Int J Cancer 2014; 135: 1918-1930.
Taylor R., Najafi F., Dobson A. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol 2007; 36: 1048-1059.
Bals R., Boyd J., Esposito S., Foronjy R., Hiemstra P. S., Jiménez-Ruiz C. A. et al. Electronic cigarettes: a task force report from the European Respiratory Society. Eur Respir J 2019; 53: 1801151.
Gotts J. E., Jordt S.-E., McConnell R., Tarran R. What are the respiratory effects of e-cigarettes? BMJ 2019; 366: l5275.
Wills T. A., Choi K., Pagano I. E-cigarette use associated with asthma independent of cigarette smoking and marijuana in a 2017 National Sample of adolescents. J Adolesc Health 2020; 67: 524-530.
Perez M. F., Atuegwu N. C., Mead E. L., Oncken C., Mortensen E. M. Adult E-cigarettes use associated with a self-reported diagnosis of COPD. Int J Environ Res Public Health 2019; 16: 20.
Xie Z., Ossip D. J., Rahman I., Li D. Use of electronic cigarettes and self-reported chronic obstructive pulmonary disease diagnosis in adults. Nicotine Tob Res 2020; 22: 1155-1161.
Li D., Sundar I. K., McIntosh S., Ossip D. J., Goniewicz M. L., O'Connor R. J. et al. Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the population assessment of tobacco and health (PATH) study. wave 2. Tob Control 2020; 29: 140-147.
Centers for Disease Control and Prevention. Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products [internet]. 2020. Available at: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html (accessed 05 August 2020).
Jonas A. M., Raj R. Vaping-related acute parenchymal lung injury: a systematic review. Chest 2020; 158: 1555-1565.
Hammond D. Outbreak of pulmonary diseases linked to vaping. BMJ 2019; 366: l5445.
Siu A. L., US Preventive Services Task Force Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2015; 163: 622-634.
Haas J. S., Linder J. A., Park E. R., Gonzalez I., Rigotti N. A., Klinger E. V. et al. Proactive tobacco cessation outreach to smokers of low socioeconomic status: a randomized clinical trial. JAMA Intern Med 2015; 175: 218-226.
Danan E. R., Joseph A. M., Sherman S. E., Burgess D. J., Noorbaloochi S., Clothier B. et al. Does motivation matter? Analysis of a randomized trial of proactive outreach to VA smokers. J Gen Intern Med 2016; 31: 878-887.
Balfour D. J. K. The neurobiology of tobacco dependence: a commentary. Respir Int Rev Thorac Dis 2002; 69: 7-11.
Hughes J. R. Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review. Nicotine Tob Res 2007; 9: 329-339.
Smith P. H., Homish G. G., Giovino G. A., Kozlowski L. T. Cigarette smoking and mental illness: a study of nicotine withdrawal. Am J Public Health 2014; 104: e127-e133.
van Eerd E. A. M., van Schayck O. C. P., Wesseling G., Kotz D. Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial. Eur Respir J 2017; 49(6): 1700561. https://doi.org/10.1183/13993003.00561-2017
Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res 2012; 14: 75-78.
World Health Organization. Cancer: Key Facts [internet]. 2018. Available at: https://www.who.int/news-room/fact-sheets/detail/cancer (accessed 15 July 2020).
Cao M., Chen W. Epidemiology of lung cancer in China. Thorac Cancer 2019; 10: 3-7.
Tsao A. S., Liu D., Lee J. J., Spitz M., Hong W. K. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer 2006; 106: 2428-2436.
Parsons A., Daley A., Begh R., Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010; 340: b5569.
Cataldo J. K., Dubey S., Prochaska J. J. Smoking cessation: an integral part of lung cancer treatment. Oncology 2010; 78: 289-301.
Bryant A., Cerfolio R. J. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest 2007; 132: 185-192.
Janjigian Y. Y., McDonnell K., Kris M. G., Shen R., Sima C. S., Bach P. B. et al. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer 2010; 116: 670-675.
Toll B.A., Brandon T.H., Gritz E.R., Warren G.W., Herbst R.S. AACR Subcommittee on Tobacco and Cancer. Assessing tobacco use by cancer patients and facilitating cessation: an American association for cancer research policy statement. Clin Cancer Res 2013; 19(8): 1941-1948. https://doi.org/10.1158/1078-0432.ccr-13-0666
Sardari Nia P., Weyler J., Colpaert C., Vermeulen P., Van Marck E., Van Schil P. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer 2005; 47: 351-359.
Tao L., Wang R., Gao Y.-T., Yuan J.-M. Impact of postdiagnosis smoking on long-term survival of cancer patients: the Shanghai cohort study. Cancer Epidemiol Biomark Prev 2013; 22: 2404-2411.
Chen J., Jiang R., Garces Y. I., Jatoi A., Stoddard S. M., Sun Z. et al. Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients. Lung Cancerh 2010; 67: 221-226.
Anthonisen N. R., Connett J. E., Kiley J. P., Altose M. D., Bailey W. C., Buist A. S. et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
Anthonisen N. R., Connett J. E., Murray R. P. Smoking and lung function of lung health study participants after 11 years. Am J Respir Crit Care Med 2002; 166: 675-679.
Kohansal R., Martinez-Camblor P., Agustí A., Buist A. S., Mannino D. M., Soriano J. B. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009; 180: 3-10.
Tashkin D. P., Rennard S., Hays J. T., Ma W., Lawrence D., Lee T. C. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest 2011; 139: 591-599.
Etter J.-F. Short-term change in self-reported COPD symptoms after smoking cessation in an internet sample. Eur Respir J 2010; 35: 1249-1255.
Josephs L., Culliford D., Johnson M., Thomas M. Improved outcomes in ex-smokers with COPD: a UK primary care observational cohort study. Eur Respir J 2017; 49: 1602114.
Tønnesen P., Pisinger C., Hvidberg S., Wennike P., Bremann L., Westin A. et al. Effects of smoking cessation and reduction in asthmatics. Nicotine Tob Res 2005; 7: 139-148.
Chaudhuri R., Livingston E., McMahon A. D., Lafferty J., Fraser I., Spears M. et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174: 127-133.
Jang A.-S., Park S.-W., Kim D.-J., Uh S., Kim Y. H., Whang H. G. et al. Effects of smoking cessation on airflow obstruction and quality of life in asthmatic smokers. Allergy Asthma Immunol Res 2010; 2: 254-259.
Zhu S., Melcer T., Sun J., Rosbrook B., Pierce J. P. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med 2000; 18: 305-311.
Verbiest M., Brakema E., van der Kleij R., Sheals K., Allistone G., Williams S. et al. National guidelines for smoking cessation in primary care: a literature review and evidence analysis. NPJ Prim Care Respir Med. 2017; 27(1). https://doi.org/10.1038/s41533-016-0004-8
West R., Raw M., McNeill A., Stead L., Aveyard P., Bitton J. et al. Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. Addiction. 2015;110(9): 1388-1403. https://doi.org/10.1111/add.12998
van Eerd E. A. M., van der Meer R. M., van Schayck O. C. P., Kotz D. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2016CD010744.
Clergue-Duval V., Lair R., Lefebvre-Durel C., Barré T., Gautron M.-A., Mehtelli W. et al. COPD positive screening with spirometry increases motivation to quit tobacco smoking in an addiction treatment center. COPD 2020; 17: 240-244.
Sharma A., Bansal-Travers M., Celestino P., Fine J., Reid M. E., Hyland A. et al. Using a smoking cessation Quitline to promote lung cancer screening. Am J Health Behav 2018; 42: 85-100.
Liang J., Abramson M. J., Zwar N. A., Russell G. M., Holland A. E., Bonevski B. et al. Diagnosing COPD and supporting smoking cessation in general practice: evidence-practice gaps. Med J Aust 2018; 208: 29-34.
Cao P., Jeon J., Levy D. T., Jayasekera J. C., Cadham C. J., Mandelblatt J. S. et al. Potential impact of cessation interventions at the point of lung cancer screening on lung cancer and overall mortality in the United States. J Thorac Oncol 2020; 15: 1160-1169.
Zeng L., Yu X., Yu T., Xiao J., Huang Y. Interventions for smoking cessation in people diagnosed with lung cancer. Cochrane Database Syst Rev 2019CD011751.
Sharma S. K., Mohan A., Singh A. D., Mishra H., Jhanjee S., Pandey R. M. et al. Impact of nicotine replacement therapy as an adjunct to anti-tuberculosis treatment and behaviour change counselling in newly diagnosed pulmonary tuberculosis patients: an open-label, randomised controlled trial. Sci Rep 2018; 8: 8828.
Goel S., Kathiresan J., Singh P., Singh R. J. Effect of a brief smoking cessation intervention on adult tobacco smokers with pulmonary tuberculosis: a cluster randomized controlled trial from North India. Ind J Public Health 2017; 61: S47-S53.
National Lung Screening Trial Research Team, Aberle D. R., Adams A. M., Berg C. D., Black W. C., Clapp J. D. et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409.
de Koning H. J., van der Aalst C. M., de Jong P. A., Scholten E. T., Nackaerts K., Heuvelmans M. A. et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 2020; 382: 503-513.